8 completed, 2 unknown. 10 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 8, Unknown 2 |
Follow Bioequivalency: new trials by email Literature Review of Bioequivalency trials Research Report on Bioequivalency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Iron Sucrose Injection in Healthy Participants Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues | Phase 1 | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 48 | 2024-11-22 | 2025-03-24 |
| Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues | Phase 1 | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 48 | 2024-06-25 | 2024-10-08 |
| A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions Ensartinib Hydrochloride - Bioequivalency | Phase 1 | Completed | Xcovery Holdings, Inc. | 32 | 2022-11-29 | 2024-02-20 |
| Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers. Darifenacin - Bioequivalency | Phase 1 | Unknown | Center for Clinical Pharmacology Research Bdbeq S.A. | 24 | 2010-12-01 | 2010-10-27 |
| Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers. Darifenacin - Bioequivalency | Phase 1 | Unknown | Center for Clinical Pharmacology Research Bdbeq S.A. | 24 | 2010-11-01 | 2010-10-25 |
| Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions Bicalutamide 50 mg Tablet vs Casodex® 50 mg Tablet - Bioequivalency | Phase 1 | Completed | Kremers Urban Development Company | 60 | 2005-05-01 | 2009-12-24 |
| Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions Naproxen Tablets, 500 mg - Bioequivalency | Phase 1 | Completed | Perrigo Company | 34 | 2004-06-01 | 2012-03-16 |
| Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions Naproxen Tablets, 500 mg - Bioequivalency | Phase 1 | Completed | Perrigo Company | 34 | 2004-06-01 | 2012-03-16 |
| Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions Ibuprofen Tablets, 800 mg - Bioequivalency | Phase 1 | Completed | Perrigo Company | 30 | 2004-01-01 | 2012-03-16 |
| Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions Ibuprofen Tablets, 800 mg - Bioequivalency | Phase 1 | Completed | Perrigo Company | 30 | 2003-11-01 | 2012-03-16 |
Cholinergic Agents (2) · Cholinergic Antagonists (2) · Ferric Oxide, Saccharated (2) · Ibuprofen (2) · Long-Term Synaptic Depression (2) · Muscarinic Antagonists (2) · Naproxen (2) · darifenacin (2) · Tablets (1) · bicalutamide (1) · ensartinib (1)
Perrigo Company (4) · Center for Clinical Pharmacology Research Bdbeq S.A. (2) · Sichuan Huiyu Pharmaceutical Co., Ltd (2) · Kremers Urban Development Company (1) · Xcovery Holdings, Inc. (1)
China (2) · Uruguay (2) · Canada (1) · United States (1)
Francisco E. Estevez-Carrizo, MD (2) · Susana Parrillo, M.D. (2) · Chun Wan (1) · Giovanni Selvaggi, MD (1) · Richard Larouche, M.D. (1)